Virtus Investment Advisers, Inc. Vertex Pharmaceuticals Inc Transaction History

Virtus Investment Advisers, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $360,634 - $402,383	1,317 New	1,317 $381,000
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $162,060 - $189,351	-1,069 Closed	0 $0
Q4 2017 Feb 26, 2018	SELL	$137.28 - $155.55 $572,320 - $648,487	-4,169 Reduced 79.59%	1,069 $160,000
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $719,072 - $814,770	5,238	5,238 $161,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.